Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease
- PMID: 17418429
- DOI: 10.1016/j.tins.2007.03.009
Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease
Abstract
Parkinson's disease arises from genetic and possibly neurotoxic causes that produce massive cell death of the neuromelanin-containing dopaminergic neurons of the substantia nigra. Loss of these neurons is essential for the diagnostic parkinsonian features. Although many genetic mutations have been suggested as causes or risk factors for Parkinson's disease, the low penetrance of some mutations and the low disease concordance in relatives suggests that there must be interactions between multiple factors. We suggest that 'multiple hits' that combine toxic stress, for example, from dopamine oxidation or mitochondrial dysfunction, with an inhibition of a neuroprotective response, such as loss of function of parkin or stress-induced autophagic degradation, underlie selective neuronal death. We discuss the properties of substantia nigra dopamine neurons that might make them particular targets of such multiple hits.
Similar articles
-
Neuronal vulnerability in Parkinson's disease.Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S52-4. doi: 10.1016/S1353-8020(11)70018-9. Parkinsonism Relat Disord. 2012. PMID: 22166454 Review.
-
Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.Histol Histopathol. 1997 Jan;12(1):25-31. Histol Histopathol. 1997. PMID: 9046040
-
The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.Brain. 1999 Aug;122 ( Pt 8):1437-48. doi: 10.1093/brain/122.8.1437. Brain. 1999. PMID: 10430830
-
Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra.Exp Neurol. 2000 Nov;166(1):127-35. doi: 10.1006/exnr.2000.7483. Exp Neurol. 2000. PMID: 11031089
-
Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease.Clin Exp Pharmacol Physiol. 2007 Jul;34(7):555-65. doi: 10.1111/j.1440-1681.2007.04616.x. Clin Exp Pharmacol Physiol. 2007. PMID: 17581209 Review.
Cited by
-
The central theme of Parkinson's disease: α-synuclein.Mol Neurobiol. 2013 Apr;47(2):460-5. doi: 10.1007/s12035-012-8369-3. Epub 2012 Nov 23. Mol Neurobiol. 2013. PMID: 23180276 Review.
-
Parkin cooperates with GDNF/RET signaling to prevent dopaminergic neuron degeneration.J Clin Invest. 2015 May;125(5):1873-85. doi: 10.1172/JCI79300. Epub 2015 Mar 30. J Clin Invest. 2015. PMID: 25822020 Free PMC article.
-
Interactions between gut microbiota and Parkinson's disease: The role of microbiota-derived amino acid metabolism.Front Aging Neurosci. 2022 Nov 2;14:976316. doi: 10.3389/fnagi.2022.976316. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36408101 Free PMC article. Review.
-
Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo.Neurobiol Aging. 2015 Sep;36(9):2617-27. doi: 10.1016/j.neurobiolaging.2015.05.008. Epub 2015 May 16. Neurobiol Aging. 2015. PMID: 26070241 Free PMC article.
-
Omics data integration suggests a potential idiopathic Parkinson's disease signature.Commun Biol. 2023 Nov 20;6(1):1179. doi: 10.1038/s42003-023-05548-w. Commun Biol. 2023. PMID: 37985891 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical